COVID-19 pandemic has made it increasingly difficult for ECS progastrin to ensure clinical research is maintained.

As a result, the sponsor made the decision to end patient enrollment prematurely.

Dosage of progastrin in asymptomatic person participating in colon cancer screening

For anyone who will participate in colon screening at the Princess Grace Hospital of Monaco and who has signed the informed consent document. A blood test will be performed in addition to the screening test to assess the rate of progastrin.

Inclusion Criteria:

• participant in colon cancer screening
• signing informed consent

Exclusion Criteria:

• any major medical, psychiatric or addictive illness that would affect the informed consent process
• The consent of a representative is not allowed in this study

Monocentric study; No IPD sharing